These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27058219)

  • 1. Global prevalence of prothrombin gene mutation G20210A and implications in women's health: a systematic review.
    Dziadosz M; Baxi LV
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):481-9. PubMed ID: 27058219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
    Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
    Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
    Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.
    Rahimi Z; Vaisi-Raygani A; Mozafari H; Kharrazi H; Rezaei M; Nagel RL
    J Thromb Thrombolysis; 2008 Jun; 25(3):280-3. PubMed ID: 17700999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classic thrombophilic gene variants.
    Mannucci PM; Franchini M
    Thromb Haemost; 2015 Nov; 114(5):885-9. PubMed ID: 26018405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia.
    Junker R; Koch HG; Auberger K; Münchow N; Ehrenforth S; Nowak-Göttl U
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2568-72. PubMed ID: 10521389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis.
    Vazquez F; Rodger M; Carrier M; Le Gal G; Reny JL; Sofi F; Mueller T; Nagpal S; Jetty P; Gandara E
    Eur J Vasc Endovasc Surg; 2015 Aug; 50(2):232-40. PubMed ID: 26092622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
    JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.
    Zivelin A; Rosenberg N; Faier S; Kornbrot N; Peretz H; Mannhalter C; Horellou MH; Seligsohn U
    Blood; 1998 Aug; 92(4):1119-24. PubMed ID: 9694698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism.
    Poli D; Antonucci E; Cecchi E; Betti I; Valdrè L; Mugnaini C; Alterini B; Morettini A; Nozzoli C; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2003 Dec; 90(6):1158-62. PubMed ID: 14652651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
    Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Risk Factors in Venous Thromboembolism.
    Hotoleanu C
    Adv Exp Med Biol; 2017; 906():253-272. PubMed ID: 27638626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin G20210A polymorphism and thrombophilia.
    Nguyen A
    Mayo Clin Proc; 2000 Jun; 75(6):595-604. PubMed ID: 10852421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.
    Linfert DR; Rezuke WN; Tsongalis GJ
    Conn Med; 1998 Sep; 62(9):519-25. PubMed ID: 9785636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.
    Ho WK; Hankey GJ; Quinlan DJ; Eikelboom JW
    Arch Intern Med; 2006 Apr; 166(7):729-36. PubMed ID: 16606808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology consultation on the laboratory evaluation of thrombophilia: when, how, and why.
    Ballard RB; Marques MB;
    Am J Clin Pathol; 2012 Apr; 137(4):553-60. PubMed ID: 22431530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.